Regulation of Autophagy in Cardiovascular Diseases by Natural Products

Adv Exp Med Biol. 2020:1207:731-736. doi: 10.1007/978-981-15-4272-5_55.

Abstract

Several major cardiovascular diseases, such as heart failure (HF) and atherosclerosis (AS), have been linked to autophagy dysfunction. The influence of autophagy on the occurrence and development of cardiovascular diseases has two sides. Generally, the induction of autophagy at a low level can provide energy and nutrients for cells through degradation of damaged organelles, protect cardiomyocytes and vascular endothelial cells, and stabilize atherosclerotic plaques. However, excessive autophagy may damage cardiomyocytes and vascular endothelial cells and even cause cell death. Therefore, the study on the role and mechanism of autophagy in the pathogenesis of cardiovascular diseases may not only provide new targets for the treatment of cardiac remodeling, myocardial ischemia and reperfusion injury, atherosclerosis and heart failure, but also provide clues for the developing new drugs on prevention and treatment of clinical cardiovascular diseases. In this chapter, we reviewed the research progress on resveratrol, curcumin, epigallocatechin-3-gallate, and cordyceps sinensis on their recent research progress for cardiovascular diseases. Regulating autophagy may be an effective strategy for the treatment of cardiovascular diseases in the future.

Keywords: Autophagy; Cardiovascular diseases; Multi-target drugs; Natural product.

Publication types

  • Review

MeSH terms

  • Autophagy / drug effects*
  • Biological Products / pharmacology*
  • Biological Products / therapeutic use*
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / pathology*
  • Endothelial Cells / drug effects
  • Endothelial Cells / pathology
  • Humans
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / pathology

Substances

  • Biological Products